Abstract:Highlights • Exploring the role of thrombospondins with multi-dimensional data, including bulk RNA-seq, scRNA-seq, spatial transcriptomics, cell line drug sensitivity, Whole Genome Sequencing, and immunohistochemical images. • We discovered that pan-dCAFs are one of the major sources of the TSP family in the colon cancer microenvironment. This CAFs subtype possesses high matrix remodeling activity. • Based on TSPs expression, patients can be divided into two clusters with distinct prognoses and immune microenvironment. • We found that THBS2 may be associated with CAFs differentiation and enhanced pro-carcinogenic activity. Moreover, we observed that the communication intensity between THBS2 + CAFs and other cells was stronger than that in THBS2 - CAFs. • A web server presenting the main findings of this study is available at http://tsp.liumwei.org/Col.Cancer . This includes all cohorts and tools used, results, and the appendix. Background Acting as mediators in cell-matrix and cell-cell communication, matricellular proteins play a crucial role in cancer progression. Thrombospondins (TSPs), a type of matricellular glycoproteins, are key regulators in cancer biology with multifaceted roles. Although TSPs have been implicated in anti-tumor immunity and epithelial-mesenchymal transition (EMT) in several malignancies, their specific roles to colon cancer remain elusive. Addressing this knowledge gap is essential, as understanding the function of TSPs in colon cancer could identify new therapeutic targets and prognostic markers. Methods Analyzing 1,981 samples from 10 high-throughput datasets, including six bulk RNA-seq, three scRNA-seq, and one spatial transcriptome dataset, our study investigated the prognostic relevance, risk stratification value, immune heterogeneity, and cellular origin of TSPs, as well as their influence on cancer-associated fibroblasts (CAFs). Utilizing survival analysis, unsupervised clustering, and functional enrichment, along with multiple correlation analyses of the tumor-microenvironment (TME) via Gene Set Variation Analysis (GSVA), spatial localization, Monocle2, and CellPhoneDB, we provided insights into the clinical and cellular implications of TSPs. Results First, we observed significant upregulation of THBS2 and COMP in colon cancer, both of which displayed significant prognostic value. Additionally, we detected a significant positive correlation between TSPs and immune cells, as well as marker genes of EMT. Second, based on TSPs expression, patients were divided into two clusters with distinct prognoses: the high TSPs expression group (TSPs-H) was characterized by pronounced immune and stromal cell infiltration, and notably elevated T-cell exhaustion scores. Subsequently, we found that THBS2 and COMP may be associated with the differentiation of CAFs into pan-iCAFs and pan-dCAFs, which are known for their heightened matrix remodeling activities. Moreover, THBS2 enhanced CAFs communication with vascular endothelial cells and monocyte-macrophages. CAFs expressing THBS2 ( THBS2 + CAFs) demonstrated higher scores across multiple signaling pathways, including angiogenic, EMT, Hedgehog, Notch, Wnt, and TGF-β, when compared to THBS2 - CAFs. These observations suggest that THBS2 may be associated with stronger pro-carcinogenic activity in CAFs. Conclusions This study revealed the crucial role of TSPs and the significant correlation between THBS2 and CAFs interactions in colon cancer progression, providing valuable insights for targeting TSPs to mitigate cancer progression. Graphical abstract Download : Download high-res image (213KB) Download : Download full-size image

Multi-scale integrative analyses identify THBS2 + cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma

Characterizing Tumor Microenvironment and Risk Genes in Lung Adenocarcinoma through scRNA-seq and Bulk RNA-seq Data

Single-cell analyzing of tumor microenvironment and cell adhesion between early and late-stage lung cancer

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.

Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma

Integrating bulk RNA-seq and scRNA-seq analyses revealed the function and clinical value of thrombospondins in colon cancer

Poor prognosis of stage I lung adenocarcinoma patients determined by elevated expression over pre/minimally invasive status of COL11A1 and THBS2 in the focal adhesion pathway

Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironment

Multi-omics profiling and experimental verification of tertiary lymphoid structure-related genes: molecular subgroups, immune infiltration, and prognostic implications in lung adenocarcinoma

Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1<SUP>+</SUP>INHBA<SUP>+</SUP>CAF as drivers of colorectal cancer progression

Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-mediated activation of the MAPK pathway

High Expression of Octamer-Binding Transcription Factor 4a, Prominin-1 and Aldehyde Dehydrogenase Strongly Indicates Involvement in the Initiation of Lung Adenocarcinoma Resulting in Shorter Disease-Free Intervals

Long Noncoding RNA SBF2-AS1 is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma

Characterization of the evolution trajectory and immune profiling of new histologic patterns in lung adenocarcinoma

THBS1 facilitates colorectal liver metastasis through enhancing epithelial–mesenchymal transition

Refining the optimal CAF cluster marker for predicting TME-dependent survival expectancy and treatment benefits in NSCLC patients

Single-cell analysis reveals the COL11A1+ fibroblasts are cancer-specific fibroblasts that promote tumor progression

A novel cancer-associated fibroblasts risk score model predict survival and immunotherapy in lung adenocarcinoma

SNAI2 as a Prognostic Biomarker Based on Cancer-Associated Fibroblasts in Patients With Lung Adenocarcinoma

Identification of CXCL13/CXCR5 axis’s crucial and complex effect in human lung adenocarcinoma

Identification ofLBX2as a novel causal gene of lung adenocarcinoma